A combined anatomic and electrophysiologic substrate based approach for sudden cardiac death risk stratification

American Heart Journal

Volumn 166, Issue 4, 2013, Pages 744-752

  Merchant, Faisal M ^a,b   Zheng, Hui ^b   Bigger, Thomas ^c   Steinman, Richard ^c   Ikeda, Takanori ^d   Pedretti, Roberto F E ^e   Salerno Uriarte, Jorge A ^f   Klersy, Catherine ^g   Chan, Paul S ^h   Bartone, Cheryl ⁱ   Hohnloser, Stefan H ^j   Ruskin, Jeremy N ^b   Armoundas, Antonis A ^b,k  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c Och Spine at New York Presbyterian Hospitals   (United States)

^d TOHO UNIVERSITY   (Japan)

^e IRCCS   (Italy)

^f UNIVERSITY OF INSUBRIA   (Italy)

^g UNIVERSITY OF PAVIA   (Italy)

^h UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

ⁱ CHRIST HOSPITAL   (United States)

^j GOETHE UNIVERSITY   (Germany)

^k MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR PARAMETERS; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; ELECTROCARDIOGRAM; ELECTROCARDIOGRAPH; FEMALE; FOLLOW UP; HEART ELECTROPHYSIOLOGY; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MAJOR CLINICAL STUDY; MALE; MICROVOLT T WAVE ALTERNAN TESTING; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SUDDEN CARDIAC DEATH; T WAVE;

DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; ELECTROPHYSIOLOGIC TECHNIQUES, CARDIAC; HUMANS; PRIMARY PREVENTION; RISK ASSESSMENT; TACHYCARDIA, VENTRICULAR;

EID: 84885175628     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2013.06.023     Document Type: Article

References (44)

1. A.J. Moss, W. Zareba, and W.J. Hall Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction N Engl J Med 346 12 2002 877 883
2. G.H. Bardy, K.L. Lee, and D.B. Mark Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure N Engl J Med 352 3 2005 225 237
3. A.E. Epstein, J.P. DiMarco, and K.A. Ellenbogen ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons Circulation 117 21 2008 e350 e408
4. C. Raphael, C. Briscoe, and J. Davies Limitations of the New York Heart Association functional classification system and self-reported walking distances in chronic heart failure Heart 93 4 2007 476 482
5. G.I. Fishman, S.S. Chugh, and J.P. Dimarco Sudden cardiac death prediction and prevention: report from a National Heart, Lung, and Blood Institute and Heart Rhythm Society Workshop Circulation 122 22 2010 2335 2348
6. A.E. Buxton, K.E. Ellison, and P. Lorvidhaya Left ventricular ejection fraction for sudden death risk stratification and guiding implantable cardioverter-defibrillators implantation J Cardiovasc Pharmacol 55 5 2010 450 455
7. E.C. Stecker, C. Vickers, and J. Waltz Population-based analysis of sudden cardiac death with and without left ventricular systolic dysfunction: two-year findings from the Oregon Sudden Unexpected Death Study J Am Coll Cardiol 47 6 2006 1161 1166
8. A.P. Gorgels, C. Gijsbers, and J. de Vreede-Swagemakers Out-of-hospital cardiac arrest-the relevance of heart failure. The Maastricht Circulatory Arrest Registry Eur Heart J 24 13 2003 1204 1209
9. S.H. Hohnloser, T. Ikeda, and R.J. Cohen Evidence regarding clinical use of microvolt T-wave alternans Heart rhythm: the official journal of the Heart Rhythm Society 6 3 Suppl 2009 S36 S44
10. M.R. Gold, D.M. Bloomfield, and J.M. Anderson A comparison of T-wave alternans, signal averaged electrocardiography and programmed ventricular stimulation for arrhythmia risk stratification J Am Coll Cardiol 36 7 2000 2247 2253
11. S.H. Hohnloser, T. Klingenheben, and D. Bloomfield Usefulness of microvolt T-wave alternans for prediction of ventricular tachyarrhythmic events in patients with dilated cardiomyopathy: results from a prospective observational study J Am Coll Cardiol 41 12 2003 2220 2224
12. E.J. Rashba, A.F. Osman, and K. Macmurdy Enhanced detection of arrhythmia vulnerability using T wave alternans, left ventricular ejection fraction, and programmed ventricular stimulation: a prospective study in subjects with chronic ischemic heart disease J Cardiovasc Electrophysiol 15 2 2004 170 176
13. D.J. Cantillon, K.M. Stein, and S.M. Markowitz Predictive value of microvolt T-wave alternans in patients with left ventricular dysfunction J Am Coll Cardiol 50 2 2007 166 173
14. M.R. Gold, J.H. Ip, and O. Costantini Role of microvolt T-wave alternans in assessment of arrhythmia vulnerability among patients with heart failure and systolic dysfunction: primary results from the T-wave alternans sudden cardiac death in heart failure trial substudy Circulation 118 20 2008 2022 2028
15. T. Chow, D.J. Kereiakes, and J. Onufer Does microvolt T-wave alternans testing predict ventricular tachyarrhythmias in patients with ischemic cardiomyopathy and prophylactic defibrillators? The MASTER (Microvolt T Wave Alternans Testing for Risk Stratification of Post-Myocardial Infarction Patients) trial J Am Coll Cardiol 52 20 2008 1607 1615
16. O. Costantini, S.H. Hohnloser, and M.M. Kirk The ABCD (Alternans Before Cardioverter Defibrillator) Trial: strategies using T-wave alternans to improve efficiency of sudden cardiac death prevention J Am Coll Cardiol 53 6 2009 471 479
17. H. Kitamura, Y. Ohnishi, and K. Okajima Onset heart rate of microvolt-level T-wave alternans provides clinical and prognostic value in nonischemic dilated cardiomyopathy J Am Coll Cardiol 39 2 2002 295 300
18. W. Grimm, M. Christ, and J. Bach Noninvasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy: results of the Marburg Cardiomyopathy Study Circulation 108 23 2003 2883 2891
19. J.M. Tapanainen, A.M. Still, and K.E.J. Airaksinen Prognostic significance of risk stratifiers of mortality, including T wave alternans, afer acute myocardial infarction: Results of a propsective follow-up study J Cardiovasc Electrophysiol 12 6 2001 645 652
20. E.Z. Gorodeski, D.J. Cantillon, and S.S. Goel Microvolt T-wave alternans, peak oxygen consumption, and outcome in patients with severely impaired left ventricular systolic function J Heart Lung Transplant 28 7 2009 689 696
21. D.M. Bloomfield, J.T. Bigger, and R.C. Steinman Microvolt T-wave alternans and the risk of death or sustained ventricular arrhythmias in patients with left ventricular dysfunction J Am Coll Cardiol 47 2 2006 456 463
22. P.S. Chan, B.K. Nallamothu, and J.A. Spertus Impact of age and medical comorbidity on the effectiveness of implantable cardioverter-defibrillators for primary prevention Circ Cardiovasc Qual Outcomes 2 1 2009 16 24
23. T. Ikeda, H. Saito, and K. Tanno T-wave alternans as a predictor for sudden cardiac death after myocardial infarction Am J Cardiol 89 1 2002 79 82
24. T. Ikeda, H. Yoshino, and K. Sugi Predictive value of microvolt T-wave alternans for sudden cardiac death in patients with preserved cardiac function after acute myocardial infarction: results of a collaborative cohort study J Am Coll Cardiol 48 11 2006 2268 2274
25. J.A. Salerno-Uriarte, G.M. De Ferrari, and C. Klersy Prognostic value of T-wave alternans in patients with heart failure due to nonischemic cardiomyopathy: results of the ALPHA Study J Am Coll Cardiol 50 19 2007 1896 1904
26. T. Klingenheben, M. Zabel, and R.B. D'Agostino Predictive value of T-wave alternans for arrhythmic events in patients with congestive heart failure [letter] Lancet 356 9230 2000 651 652
27. D.S. Rosenbaum, L.E. Jackson, and J.M. Smith Electrical alternans and vulnerability to ventricular arrhythmias N Engl J Med 330 4 1994 235 241
28. D.M. Bloomfield, S.H. Hohnloser, and R.J. Cohen Interpretation and classification of microvolt T wave alternans tests J Cardiovasc Electrophysiol 13 5 2002 502 512
29. D.L. Packer, J.M. Prutkin, and A.S. Hellkamp Impact of implantable cardioverter-defibrillator, amiodarone, and placebo on the mode of death in stable patients with heart failure: analysis from the sudden cardiac death in heart failure trial Circulation 120 22 2009 2170 2176
30. A. Gupta, D.D. Hoang, and L. Karliner Ability of microvolt T-wave alternans to modify risk assessment of ventricular tachyarrhythmic events: a meta-analysis Am Heart J 163 3 2012 354 364
31. P.W. Wilson, R.B. D'Agostino, and D. Levy Prediction of coronary heart disease using risk factor categories Circulation 97 18 1998 1837 1847
32. P.M. Ridker, J.E. Buring, and N. Rifai Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score JAMA 297 6 2007 611 619
33. R.S. Velagaleti, P. Gona, and M.G. Larson Multimarker approach for the prediction of heart failure incidence in the community Circulation 122 17 2010 1700 1706
34. W.B. Kannel, R.B. D'Agostino, and H. Silbershatz Profile for estimating risk of heart failure Arch Intern Med 159 11 1999 1197 1204
35. A.E. Buxton, K.L. Lee, and G.E. Hafley Limitations of ejection fraction for prediction of sudden death risk in patients with coronary artery disease: lessons from the MUSTT study J Am Coll Cardiol 50 12 2007 1150 1157
36. I. Goldenberg, A.K. Vyas, and W.J. Hall Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction J Am Coll Cardiol 51 3 2008 288 296
37. B.D. Atwater, V.P. Thompson, and R.N. Vest III Usefulness of the Duke Sudden Cardiac Death risk score for predicting sudden cardiac death in patients with angiographic (>75% narrowing) coronary artery disease Am J Cardiol 104 12 2009 1624 1630
38. P.A. Scott, J.A. Rosengarten, and N.P. Curzen Late gadolinium enhancement cardiac magnetic resonance imaging for the prediction of ventricular tachyarrhythmic events: a meta-analysis Eur J Heart Fail 2013 [Epub ahead of print]
39. M.J. Boogers, C.J. Borleffs, and M.M. Henneman Cardiac sympathetic denervation assessed with 123-iodine metaiodobenzylguanidine imaging predicts ventricular arrhythmias in implantable cardioverter-defibrillator patients J Am Coll Cardiol 55 24 2010 2769 2777
40. A. Kadish, A. Dyer, and J.P. Daubert Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy N Engl J Med 350 21 2004 2151 2158
41. A.C. Pouleur, E. Barkoudah, and H. Uno Pathogenesis of sudden unexpected death in a clinical trial of patients with myocardial infarction and left ventricular dysfunction, heart failure, or both Circulation 122 6 2010 597 602
42. S.S. Chugh, J. Jui, and K. Gunson Current burden of sudden cardiac death: multiple source surveillance versus retrospective death certificate-based review in a large U.S. community J Am Coll Cardiol 44 6 2004 1268 1275
43. K.A. Ellenbogen, J.H. Levine, and R.D. Berger Are implantable cardioverter defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy? Circulation 113 6 2006 776 782
44. A.J. Moss, C. Schuger, and C.A. Beck Reduction in inappropriate therapy and mortality through ICD programming N Engl J Med 367 24 2012 2275 2283